LA
RMD icon

LVW Advisors’s ResMed RMD Stock Holding History

LVW Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,265
Closed -$284K – 491
2026
Q1 		$284K Sell
1,265
-457
-27% -$114K 0.03% 345
2025
Q4 		$415K Sell
1,722
-1,213
-41% -$310K 0.04% 223
2025
Q3 		$803K Sell
2,935
-645
-18% -$176K 0.08% 122
2025
Q2 		$924K Buy
3,580
+908
+34% +$217K 0.1% 121
2025
Q1 		$598K Sell
2,672
-426
-14% -$99.5K 0.07% 157
2024
Q4 		$708K Buy
3,098
+587
+23% +$141K 0.09% 144
2024
Q3 		$613K Buy
2,511
+1,150
+84% +$257K 0.08% 163
2024
Q2 		$261K Buy
+1,361
New +$276K 0.04% 251

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
TIA
Tandem Investment Advisors Charleston, South Carolina $1.49B AUM 12.33% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
AS
Aware Super Sydney, Australia $7.06B AUM
TIM
Triodos Investment Management Driebergen-Rijsenburg, Netherlands $1.64B AUM 37.98% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

LVW Advisors's RMD Position: Q2 2026 in Review

LVW Advisors sold out of ResMed (RMD) in Q2 2026, closing a stake of 1,265 shares — an estimated $284K sold.

LVW Advisors first reported a position in RMD in Q2 2024 and held it in 8 quarters. The position peaked at $924K in Q2 2025. 319 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • LVW Advisors reported no remaining ResMed position as of Q2 2026 after selling out during the quarter.
  • LVW Advisors sold 1,265 ResMed shares in Q2 2026, an estimated $284K.
  • LVW Advisors first reported a position in ResMed in Q2 2024 and held it in 8 quarters.
  • LVW Advisors's ResMed position peaked at $924K in Q2 2025.
  • 319 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on LVW Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.